Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene

Bipolar Disorders

Volumn 10, Issue 5, 2008, Pages 580-587

  Vincze, Ilona ^a   Perroud, Nader ^a,e   Buresi, Catherine ^a   Baud, Patrick ^a   Bellivier, Frank ^b   Etain, Bruno ^b   Fournier, Claire ^a   Karege, Felicien ^a   Matthey, Marie Louise ^c   Preisig, Martin ^c   Leboyer, Marion ^b   Malafosse, Alain ^a,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d University Hospital and Faculty of Medicine   (Switzerland)

^e Service de Psychiatrie Adulte   (Switzerland)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor; Gene gene interaction; Serotonin transporter; Suicidal behavior

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GENOMIC DNA; METHIONINE; SEROTONIN TRANSPORTER; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DNA ISOLATION; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDAL BEHAVIOR;

ADULT; ALLELES; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE SUSCEPTIBILITY; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE, ATTEMPTED;

EID: 48949120489     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2008.00603.x     Document Type: Article

References (37)

1. Duman RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998; 44: 324-335.
2. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001; 158: 100-106.
3. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M et al. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 2006; 16: 620-624.
4. Neumeister A, Yuan P, Young T et al. Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 2005; 162: 805-807.
5. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005; 136: 29-37.
6. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804-815.
7. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
8. Sklar P, Gabriel SB, McInnis MG et al. Family-based association study of 76 canditate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002; 7: 579-593.
9. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700.
10. Strauss J, Barr CL, George CJ et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet Part B (Neuropsychiatr Genet) 2004; 131: 16-19.
11. Okada T, Hashimoto R, Numakawa T et al. A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry 2006; 11: 695-703.
12. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
13. Lyons WE, Mamounas LA, Ricaurte GA et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96: 15239-15244.
14. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4: 819-828.
15. Dean B. The neurobiology of bipolar disorder: Findings using human postmortem central nervous system tissue. Aust N Z J Psychiatry 2004; 38: 135-140.
16. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II suicidal behavior. Mol Psychiatry 2003; 8: 646-653.
17. Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: Results of a meta-analysis. Biol Psychiatry 2004; 55: 1023-1030.
18. Ren-Patterson RF, Cochran LW, Holmes A et al. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005; 79: 756-771.
19. Nurnberger JI, Blehar MC, Kaufmann CA et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849-864.
20. Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F. Diagnostic interview for genetic studies (DIGS): Inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci 1999;249: 174-179.
21. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193-1197.
22. Wang L, Luhm R, Lei M. SNP and mutation analysis. Adv Exp Med Biol 2007; 593: 105-116.
23. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 2000; 10: 1249-1258.
24. Courtet P, Picot MC, Bellivier F et al. Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biol Psychiatry 2004; 55: 46-51.
25. Sham PC, Curtis D. Monte Carlo tests for association between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59: 97-105.
26. Armitage P, Berry G. Statistical Methods in Medical Research. Cambridge, MA: Blackwell Publishers, 1987: 371-407.
27. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
29. Kremeyer B, Herzberg I, Garcia J et al. Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 435-439.
30. Ren-Patterson RF, Cochran LW, Holmes A, Lesch KP, Lu B, Murphy DL. Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol 2006; 26: 755-780.
31. Kaufman J, Yang BZ, Douglas-Palumberi H et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59: 673-680.
32. Hu XZ, Lipsky RH, Zhu G et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genetics 2006; 78: 815-826.
33. Hoh J, Ott J. Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet 2003; 4: 701-709.
34. Tramontina J, Frey BN, Andreazza AC, Zandona M, Santin A, Kapczinski F. Val66Met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry 2007; 12: 230-231.
35. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007; 61: 911-922.
36. Carter TDC, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003; 37: 297-303.
37. Skibinska M, Hauser J, Czerski PM et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5: 215-220.